PENOBSCOT BAY MEDICAL CENTER
1. Target Overview & Investment Thesis
PENOBSCOT BAY MEDICAL CENTER is a 81-bed under-performing / distressed in KNOX, ME with $171.6M in net patient revenue and a -21.7% operating margin. The hospital serves a payer mix of 26.1% Medicare, 10.0% Medicaid, and 63.9% commercial.
Thesis: Turnaround. Our ML models identify $12.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -21.7% to -14.3% (+736bps).
| Net Revenue HCRIS | $171.6M |
| Current EBITDA COMPUTED | $-37.2M |
| Operating Margin COMPUTED | -21.7% |
| Occupancy HCRIS | 63.3% |
| Revenue / Bed COMPUTED | $2.1M |
| Net-to-Gross HCRIS | 42.0% |
| Distress Probability ML | 46.4% |
2. Market Context & Competitive Position
ME has 38 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -21.7% places it below the state median. Among 14 size-comparable peers (40-162 beds), the median margin is -10.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (40-162), prioritizing same-state peers. 14 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| PENOBSCOT BAY MEDICAL CENTER (Target) | ME | 81 | $171.6M | -21.7% |
| SOUTHERN MAINE HEALTH CARE | ME | 140 | $352.3M | -9.9% |
| MERCY HOSPITAL | ME | 77 | $240.0M | -11.6% |
| MID COAST HOSPITAL | ME | 93 | $213.6M | -14.0% |
| YORK HOSPITAL | ME | 54 | $197.1M | -3.6% |
| ST. MARYS REGIONAL MEDICAL CEN | ME | 140 | $196.3M | -32.8% |
| ST JOSEPH HOSPITAL | ME | 99 | $176.8M | -9.2% |
| FRANKLIN MEMORIAL HOSPITAL | ME | 46 | $103.4M | -17.3% |
| MAINE COAST MEMORIAL HOSPITAL | ME | 45 | $98.0M | -5.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $12.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.6M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $2.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $110K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-37.2M |
| + RCM Uplift | +$12.6M |
| Pro Forma EBITDA | $-24.5M |
| Current Margin | -21.7% |
| Pro Forma Margin | -14.3% |
| WC Released (1x) | $6.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-57.2M | $-118.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-57.2M | $-149.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-51.5M | $-126.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-51.5M | $-152.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-62.9M | $-163.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-62.9M | $-200.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 14 hospitals with 40-162 beds
- Same-state prioritization (n=15)
- Comp margins: P25=-14.9% / P50=-10.6% / P75=-5.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.